Altimmune, Inc. · NASDAQ:ALT
BlackRock, Inc. reported a 8.70% stake in Altimmune, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc. reported a 8.70% stake in Altimmune, Inc., 6,159,305 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).
- Stake
- 8.70%
- Shares
- 6,159,305
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 8.70% | 6,159,305 |
Source
Related
- Altimmune, Inc.
- BlackRock, Inc.
- Altimmune, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 16, 2025
- Form 4 · Weaver Gregory L · Oct 5, 2026
- Form 4 · Arbet-Engels Christophe · Oct 5, 2026
- Form 4 · Richardson Linda M · Sep 17, 2026
- Form 4 · Durso Jerome Benedict · Aug 13, 2026
- Form 4 · Roberts M Scot · Aug 3, 2026